ConductScience.org, home

Trial · NCT07895784

Effectiveness Of Project EX: A Classroom-Based Smoking Prevention And Cessation Intervention Program

NCT07895784, Not applicable, Not yet recruiting, University of Karachi

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Effectiveness Of Project EX: A Classroom-Based Smoking Prevention And Cessation Intervention Program. Trials, record NCT07895784. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07895784

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Effectiveness Of Project EX: A Classroom-Based Smoking Prevention And Cessation Intervention Program
NCT number
NCT07895784
Status
Not yet recruiting
Phases
Not applicable
Enrollment
600 participants, estimated
Lead sponsor
University of Karachi
Conditions
Focus of the Study is Smoking Cessation and Prevention, Smoking Prevention
Interventions
Project EX
First posted
2026-10-26
Last updated
2026-10-26

Source ClinicalTrials.gov

Registered outcomes12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange from Baseline in Mean motivation to quit tobacco use Score .Baseline, 6 weeks (post-intervention), and 6 months (follow-up)Measured with self-report items on the likelihood of motivation to quit in the future. Lower scores indicate greater motivation to quit.
PrimaryChange from Baseline in Mean Smoking Intention Score.Baseline, 6 weeks (post-intervention), and 6 months (follow-up)Measured with self-report items on the likelihood of smoking in the future. Lower scores indicate greater intention to smoke.
PrimaryChange from Baseline in Mean Tobacco norm attitude ScoreBaseline, 6 weeks (post-intervention), and 6 months (follow-up)Scale assessing perceived acceptability of tobacco use among peers. Lower scores indicate more favorable attitudes toward tobacco use.
PrimaryChange from Baseline in Mean Self control ScoreBaseline, 6 weeks (post-intervention), and 6 months (follow-up)Scale assessing self control items. Higher scores indicate greater self-control.
PrimaryChange from Baseline in Mean depression ScoreBaseline, 6 weeks (post-intervention), and 6 months (follow-up)Measured with the Center for Epidemiologic Studies Depression Scale (CES-D). Higher scores indicate more depressive symptoms.
PrimaryChange from Baseline in Smoking-Related KnowledgeBaseline, 6 weeks (post-intervention), and 6 months (follow-up)Measured the health consequences of smoking. Higher scores indicate greater knowledge.
PrimaryChange from Baseline in Endorsement of Tobacco Use MythsBaseline, 6 weeks (post-intervention), and 6 months (follow-up)Measured on common misconceptions about tobacco use.
PrimaryChange from Baseline in Tobacco Use BehaviorBaseline, 6 weeks (post-intervention), and 6 months (follow-up)Measured with self-report items on frequency and amount of tobacco use (cigarettes and other tobacco products) in the past 30 days. Higher scores indicate greater tobacco use.
PrimaryChange from Baseline in Quit AttemptsBaseline, 6 weeks (post-intervention), and 6 months (follow-up)Measured with self-report items on whether, and how many times, students who use tobacco tried to quit since the previous assessment.
PrimaryChange from Baseline in CopingBaseline, 6 weeks (post-intervention), and 6 months (follow-up)Measured with items assessing ways of coping with stress and difficult situations without tobacco use. This scale's items are divided into good coping and bad coping

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07895784

GET https://conductscience.org/api/trials/v1/NCT07895784/registered